Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Igm Biosciences Inc (IGMS)

Igm Biosciences Inc (IGMS)
1.3800 unch (unch) 12:57 ET [NASDAQ]
1.3700 x 8 1.3800 x 1
Realtime by (Cboe BZX)
1.3700 x 8 1.3800 x 1
Realtime 1.3800 unch (unch) 08:33 ET
Quote Overview for Mon, Feb 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.2900
Day High
1.3900
Open 1.3900
Previous Close 1.3800 1.3800
Volume 130,463 130,463
Avg Vol 345,428 345,428
Stochastic %K 28.86% 28.86%
Weighted Alpha -81.81 -81.81
5-Day Change -0.0650 (-4.55%) -0.0650 (-4.55%)
52-Week Range 1.2600 - 22.5000 1.2600 - 22.5000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 82,060
  • Shares Outstanding, K 59,464
  • Annual Sales, $ 2,130 K
  • Annual Income, $ -246,420 K
  • EBIT $ -235 M
  • EBITDA $ -236 M
  • 60-Month Beta 0.03
  • Price/Sales 28.40
  • Price/Cash Flow N/A
  • Price/Book 1.04

Options Overview Details

View History
  • Implied Volatility 256.06% ( +32.45%)
  • Historical Volatility 319.06%
  • IV Percentile 95%
  • IV Rank 39.16%
  • IV High 577.23% on 02/11/25
  • IV Low 49.32% on 08/20/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 14
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 1,910
  • Open Int (30-Day) 1,812

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.72
  • Number of Estimates 7
  • High Estimate -0.62
  • Low Estimate -0.81
  • Prior Year -1.01
  • Growth Rate Est. (year over year) +28.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2600 +8.33%
on 02/11/25
Period Open: 1.6900
1.7100 -20.18%
on 01/27/25
-0.3250 (-19.23%)
since 01/24/25
3-Month
1.2600 +8.33%
on 02/11/25
Period Open: 8.8900
11.6200 -88.25%
on 12/03/24
-7.5250 (-84.65%)
since 11/22/24
52-Week
1.2600 +8.33%
on 02/11/25
Period Open: 12.9400
22.5000 -93.93%
on 09/17/24
-11.5750 (-89.45%)
since 02/23/24

Most Recent Stories

More News
IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs

IGMS : 1.3750 (-0.36%)
Snowflake Stock Jumps Over 21% In Premarket Following Beat-and-Raise Q3: Retail Brace For ‘Parabolic’ Run

Snowflake CEO Sridhar Ramaswamy said, “Our obsessive drive to produce product cohesion and ease of use has built Snowflake into the easiest and most cost effective enterprise data platform.”

SNOW : 171.33 (-3.69%)
IGMS : 1.3750 (-0.36%)
IWL : 148.55 (+0.05%)
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update

IGMS : 1.3750 (-0.36%)
IGM Biosciences to Present at Three Upcoming Investor Conferences

IGMS : 1.3750 (-0.36%)
Stock Index Futures Mixed Ahead of U.S. JOLTs Report and Fed Speak, Nike Earnings on Tap

December S&P 500 E-Mini futures (ESZ24) are down -0.13%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.06% this morning as investors awaited the latest reading on U.S. job openings, comments...

CVS : 63.34 (-0.22%)
AAPL : 247.56 (+0.82%)
MKC : 81.79 (+2.06%)
IGMS : 1.3750 (-0.36%)
F : 9.35 (+0.75%)
NQZ24 : 20,947.98s (-0.78%)
MU : 97.71 (-1.14%)
HPQ : 35.05 (+1.21%)
NKE : 80.28 (+4.94%)
1COV.D.DX : 58.680 (-0.10%)
PAYX : 150.19 (+1.13%)
UPS : 116.86 (+0.46%)
Change in Medivir's Board of Directors

/PRNewswire/ -- Medivir AB (Nasdaq: MVIR) and (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of...

IGMS : 1.3750 (-0.36%)
Fostrox + Lenvima continues to show promising tumor control in HCC, all patients have now dosed at least two treatment cycles

/PRNewswire/ -- Medivir AB (Nasdaq:MVIR) (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high...

IGMS : 1.3750 (-0.36%)
Medivir to present at the Pareto Securities Healthcare Conference

/PRNewswire/ -- Medivir AB (Nasdaq: MVIR) (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high...

IGMS : 1.3750 (-0.36%)
Medivir's Partner Tango Therapeutics received FDA clearance to start the TNG348 phase 1/2 clinical study

/PRNewswire/ -- Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet...

IGMS : 1.3750 (-0.36%)
Medivir presents data on additive activity of fostrox in combination with Lenvima or sorafenib in non-clinical tumor models at ILCA

/PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancers with high unmet medical...

IGMS : 1.3750 (-0.36%)

Business Summary

IGM Biosciences Inc. is a biotechnology company. It engages in the research and development of engineered Immunoglobulin M antibodies for the treatment of cancer patients. The company's lead product candidate is IGM-2323, a bispecific T cell engaging IgM, which are in clinical stage. IGM Biosciences...

See More

Key Turning Points

3rd Resistance Point 1.5600
2nd Resistance Point 1.5200
1st Resistance Point 1.4500
Last Price 1.3750
1st Support Level 1.3400
2nd Support Level 1.3000
3rd Support Level 1.2300

See More

52-Week High 22.5000
Fibonacci 61.8% 14.3863
Fibonacci 50% 11.8800
Fibonacci 38.2% 9.3737
Last Price 1.3750
52-Week Low 1.2600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Mastering Fibonacci: The Hidden Order in Market Movements